Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE Trial

By afschroeder • November 12, 2025

Diggs MR, Chu SM, Fitch KV, Olefsky M, Watanabe MG, Erlandson KM, Lu AB, Bloomfield GS, Currier JS, Curran A, Eckard AR, Smith GHR, Sponseller CA, Fichtenbaum CJ, Malvestutto CD, Aberg JA, Foldyna B, Taron J, Karady J, Zanni MV, Douglas PS, Ribaudo HJ, Lu MT, Grinspoon SK. Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE Trial. AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004401. Epub ahead of print. PMID: 41217428.

Tags: atherosclerotic cardiovascular disease, cardiovascular disease, Coronary CTA, health-related quality of life, HIV, Infectious Diseases, Publications, Statins

Frailty Is Associated With Lower Urinary Tract Symptoms in Adults With and Without HIV

Abelman RA, Ma Y, Margolick JB, Erlandson KM, Greene M, Suskind AM, Taylor T, Rinaldo CR, Floris-Moore M, Chew KW, French AL, Markland AD, Stosor[...]

Enabling Ciprofloxacin Resistance-Guided Therapy for Neisseria gonorrhoeae: Aligning Diagnostics, Regulation, Guidelines, and Reimbursement

Trainor BW, Osborn JL, Klausner JD, Satlin MJ, Buss SN, Scheffer-Wong A, Harris A, Van Der Pol B, Deal C, Nenninger A, Mokany E, Moon[...]

Changes in attitudes toward the HPV vaccine in Kenya

Moucheraud C, Miao J, Ochieng E, Zhang S, Ganda G, Golub G, Hoffman RM, Szilagyi PG, Suen SC. Changes in attitudes toward the HPV vaccine[...]